WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012046260) USE OF A PHOSPHOPEPTIDE ABLE TO BLOCK HER3/P85 INTERACTION FOR THE TREATMENT OF HER2 HYPER-EXPRESSING TUMOURS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/046260    International Application No.:    PCT/IT2011/000336
Publication Date: 12.04.2012 International Filing Date: 29.09.2011
IPC:
A61K 38/18 (2006.01), A61P 35/00 (2006.01), A61K 31/138 (2006.01), A61K 31/337 (2006.01), A61K 31/555 (2006.01), A61K 31/675 (2006.01), A61K 31/704 (2006.01), A61K 39/395 (2006.01)
Applicants: ISTITUTI FISIOTERAPICI OSPITALIERI [IT/IT]; Via Elio Chianesi, 53 I-00128 Roma (IT) (For All Designated States Except US).
FALCIONI, Rita [IT/IT]; (IT) (For US Only).
FOLGIERO, Valentina [IT/IT]; (IT) (For US Only).
DI CARLO, Selene Eleonora [IT/IT]; (IT) (For US Only).
BON, Giulia [IT/IT]; (IT) (For US Only)
Inventors: FALCIONI, Rita; (IT).
FOLGIERO, Valentina; (IT).
DI CARLO, Selene Eleonora; (IT).
BON, Giulia; (IT)
Agent: GITTO, Serena; Barzano' & Zanardo Roma S.p.A Via Piemonte, 26 I-00187 Roma (IT)
Priority Data:
RM2010A000517 04.10.2010 IT
Title (EN) USE OF A PHOSPHOPEPTIDE ABLE TO BLOCK HER3/P85 INTERACTION FOR THE TREATMENT OF HER2 HYPER-EXPRESSING TUMOURS
(FR) UTILISATION D'UN POLYPEPTIDE CAPABLE DE BLOQUER L'INTERACTION HER3/P85 DANS LE TRAITEMENT DE TUMEURS HYPER-EXPRIMANT HER2
Abstract: front page image
(EN)The present invention concerns the use of a phosphopeptide able to block HER3/p85 interaction for the treatment of HER2 hyper-expressing tumours, such as, for example, metastatic mammary tumour, possibly in combination with other anti-tumour agents like, for example, trastuzumab
(FR)Cette invention concerne l'utilisation d'un phosphopeptide capable de bloquer l'interaction de HER3/p85 dans le traitement de tumeurs hyper-exprimant HER2 telles qu'une tumeur du sein métastatique, éventuellement en association avec d'autres agents anti-tumoraux, par exemple le tastuzumab.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: Italian (IT)